Business
Experts sound alarm over global spread of dangerous marijuana viroid
The dangerous and infectious hop latent viroid that’s been on the radar of many marijuana growers since its discovery in 2018 has spread beyond North America and is threatening to spiral out of control and cause billions of dollars in industry losses, experts are warning.
Researchers are calling the viroid – which is surfacing across the world – “a hidden threat” and the “biggest concern for cannabis and hop growers worldwide.”
“It’s an all-out crisis,” said Av Singh, a Canadian cannabis cultivation adviser also working as the chief science officer of Green Gorilla, a Malibu, California-based manufacturer and online retailer of hemp-derived CBD oils, topicals and pet products.
“I think we’re not recognizing how big of a crisis it is.”
Zamir Punja, a professor of plant biology for Simon Fraser University in British Columbia, Canada, said hop latent viroid (HpLVd) is the No. 1 plant pathogen that the cannabis industry needs to be concerned about.
“You can’t adjust anything, such as environmental controls, to fight it,” Punja said. “It’s either there or it’s not.
“And once it’s there, and it’s not recognized, then you just automatically spread it.”
Growers can take preventive steps to curb the spread of the viroid, which can be transmitted from plant to plant through a variety of ways, according to experts.
But it’s hard to stop and might never be eliminated, experts said.
Oussama Badad, co-founder and chief scientific officer of Growmics, a plant research company in Carbondale, Illinois, said the viroid “remains a mystery.”
“The problem is the cannabis industry for the past 20 years at least was based on clones only,” Badad said.
“So everybody is shipping clones from here to there, and nobody was testing, or nobody was aware of any methodology to test for this virus.
“What we did was basically spread it all over the planet. Anybody receiving any plants from the United States, especially from California, has the viroid in their grow.”
Small and stealthy
Experts warned the viroid is stealthy. It’s also very small, asymptomatic and waiting for an opportunity to infect a plant.
The most likely form of transmission is from the everyday trim tools used for vegetative propagation and grafting or human hands.
When the viroid attacks, the plant pathogen moves quickly from the roots to the leaves to the flower in two to three weeks, Punja said.
It is most problematic in hydroponics – rather than outdoor grows – because the viroid can move through water and more easily infect roots that tend to be matted together.
Hop latent viroid doesn’t outright kill the plant.
But a grower can see an infected plant struggling to grow normally because the plant is shorter and the trichomes are underdeveloped or stunted.
The result: lower THC and CBD levels, which can drop as much as 40%.
“It’s almost like the plant just doesn’t have that energy to put into those trichomes,” Punja said.
It’s most noticeable when the plant flowers, Punja said.
He and other researchers suggest it’s that part of the growing cycle where the viroid might become more virulent, perhaps because of the stress the hydroponic plant is undergoing during the 12-hours-on, 12-hours-off lighting change that occurs during the flowering stage.
As a precaution, growers should have their plants tested, down to the roots, Punja said.
But even then, there are no assurances.
“Unfortunately, one test is not enough,” Punja said. “What we’re finding is that the first test will be negative.
“Three weeks later, again negative. Then three weeks later, positive.”
It’s unavoidable
The viroid is likely to be in the soil of grows, researchers said. It’s also in the water of a hydroponic grow. And it’s definitely in the roots.
In addition, the pathogen is in the seed, not on the seed. It also can spread to one’s hands as a grower handles plants, moves them, stacks them, hangs them.
Even one infected plant brushing up against another can transfer the viroid.
Any sort of sap-sucking insect that makes a hole in the plant, especially at the roots, can create a pathway to infection.
The insect itself does not carry the viroid from plant to plant, as far as researchers know now, Punja said.
The viroid also could be airborne. “Other viroids are,” Singh said. “So it may not be that big a stretch to say that it would be in the pollen.”
The viroid is likely to be present in most commercial licensed cannabis production facilities in the United States and Canada.
The frequency of infected plants is estimated to be in the range of 25%-50% in both countries, according to Punja.
Testing by clone cultivator Dark Heart Nursery on 100 cannabis growers in California from August 2018 to July 2021 found that one-third of plants in 90% of those grows were infected.
That finding supports projections that the viroid affects more than 30% of all cannabis plants in the United States.
“This translates into more than $4 billion in annual losses for U.S. growers who were expected to produce more than 7 million pounds of legal cannabis in 2021,” Jeremy Warren, director of plant science for Oakland-based Dark Heart, told MJBizDaily via email.
The viroid is believed to have been first identified at Glass House Farms, which has 5.5 million square feet of total cannabis greenhouse space in Ventura County, California.
Glass House cultivators noticed their plants looking stunted, with a lack of terpenes and cannabinoids, according to company President Graham Farrar, who said he began working with Phylos Bioscience, an Oregon-based cannabis biotech firm, and Dark Heart in 2017 to determine what was really going on.
“It’s actually hard to identify that it’s infected, because the plant looks fairly healthy,” Farrar said.
“If you have six plants and one of them is funky, you think it’s the plant.
“But when you have 10,000 plants, like in our facility, and they’re being fed the exact same nutrient recipe and it’s automated in the same greenhouse and it’s the same strain, then all of a sudden, 10% or 20% of your plants are not producing the way they should, you don’t just say, ‘That’s a bad plant.’
“You start kind of digging into it.”
An RNA sample from an infected plant from Farrar’s grow was examined in a lab, and sequenced, where the lab identified the genome matching the viroid.
“I’d be surprised if (the viroid) is something that ever is gone,” Farrar said. “I think it’s probably something that we’re going to have to live with.”
How to fight it
Help is on the way from multiple sources.
Dark Heart has developed a genetic test to differentiate infected plants from uninfected ones.
The company also helped develop a patent-pending cleaning process to eliminate the viroid from infected specimens.
The Dark Heart lab team has demonstrably eliminated the viroid in 31 strains so far, according to a news release.
In May 2021, Colorado-based Front Range Biosciences introduced a method of cleaning infected plants using tissue culture.
And last month,, Biomerieux, a French diagnostics solutions company, developed a kit to test for the presence of the viroid.
“The solution is good biosecurity SOPs (standard operating procedures) and testing,” Farrar said.
“The viroid is tough, and it is persistent. The latent part is both a blessing and a curse,” he continued. “Right now, it’s nice that it doesn’t wipe out an entire greenhouse.
“But the latent part also makes it particularly hard for testing. If there’s a hope to get rid of it, that would be CRISPR genetic engineering or using selective breeding to breed plants that are resistant to it. So that’s a potential down the road.”
For now, so-called “living soil” can work as a sort of health insurance, Singh said.
“You are trying to optimize the health of the plant. You may not necessarily get as high a yield. You may not get high potency.
“But you have a more robust plant that can definitely keep some of these viruses and viroids more latent or asymptomatic.”
Glass House would like to assist growers in dealing with this viroid crisis.
“I definitely think we’d like to help people get to the point where they can test at a frequency and at a cost that’s affordable,” Farrar said.
“I don’t know if we’ll ever be able to eradicate the viroid, but at least we can keep it at a very low level so that it doesn’t have a negative impact.”
Source: https://mjbizdaily.com/experts-sound-alarm-over-global-spread-of-cannabis-viroid/
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy